HighTower Advisors
IMGN

HighTower Advisors’s Immunogen Inc IMGN Stock Holding History

HighTower Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,000
Closed -$1K – 2570
2019
Q3 		$1K Buy
15,000
+2,000
+15% +$5.31K ﹤0.01% 2401
2019
Q2 		$10K Buy
+13,000
New +$30.7K ﹤0.01% 2292

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors's IMGN Position: Q1 2022 in Review

HighTower Advisors sold out of Immunogen Inc (IMGN) in Q1 2022, closing a stake of 10,713 shares — an estimated $77K sold.

HighTower Advisors first reported a position in IMGN in Q4 2015 and held it in 17 quarters. The position peaked at $485K in Q2 2020. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • HighTower Advisors reported no remaining Immunogen Inc position as of Q1 2022 after selling out during the quarter.
  • HighTower Advisors sold 10,713 Immunogen Inc shares in Q1 2022, an estimated $77K.
  • HighTower Advisors first reported a position in Immunogen Inc in Q4 2015 and held it in 17 quarters.
  • HighTower Advisors's Immunogen Inc position peaked at $485K in Q2 2020.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on HighTower Advisors's 13F filing for Q1 2022, filed 12 May 2022.